Targeting HER2 in urothelial carcinoma: from pathway inhibition to antibody–drug conjugates
Cancer Treatment Reviews · 2026-07 · 148 · 103173
DOI: 10.1016/j.ctrv.2026.103173 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2026-07. Verfasst von Hamed Wafa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Erb-b2 Receptor Tyrosine Kinases, Immunoconjugates, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, Innsbruck, Austria.
- Division of Experimental Urology, Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.
- Institute of General Pathology, Medical University Innsbruck, Innsbruck, Austria.
- Translational Oncology, II. Med Clinics Hematology and Oncology, Augsburg, Germany.
- Department of Urology, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcala, Madrid, Spain.
- Division of Clinical Oncology, Department of Internal Medicine, Medical University Graz, Graz, Austria.
Zitieren
APA
Wafa, H., van Creij, N. C. H., Guenther, M., Noeparast, M., Subiela, J. D., Terbuch, A., Niedersuess-Beke, D., Culig, Z., Ormanns, S., & Pichler, R. (2026). Targeting HER2 in urothelial carcinoma: from pathway inhibition to antibody–drug conjugates. Cancer Treatment Reviews, 148, 103173. https://doi.org/10.1016/j.ctrv.2026.103173
Vancouver
Wafa H, van Creij NCH, Guenther M, Noeparast M, Subiela JD, Terbuch A, et al. Targeting HER2 in urothelial carcinoma: from pathway inhibition to antibody–drug conjugates. Cancer Treatment Reviews. 2026;148:103173. doi:10.1016/j.ctrv.2026.103173
BibTeX
@article{Wafa2026,
author = {Wafa, Hamed and van Creij, Nils C H and Guenther, Michael and Noeparast, Maxim and Subiela, Jose Daniel and Terbuch, Angelika and Niedersuess-Beke, Dora and Culig, Zoran and Ormanns, Steffen and Pichler, Renate},
title = {Targeting HER2 in urothelial carcinoma: from pathway inhibition to antibody–drug conjugates},
journal = {Cancer Treatment Reviews},
year = {2026},
volume = {148},
pages = {103173},
doi = {10.1016/j.ctrv.2026.103173}
}
EUVIMED